Smoking influences response to inhaled corticosteroids in patients with asthma: a meta-analysis

Abstract Objective: To determine the effects of smoking on efficacy of inhaled corticosteroids in asthmatics. Research design and methods: Prospective/retrospective, controlled studies published up to May 2012 in smokers versus non-smokers with asthma using inhaled corticosteroids (ICSs) were retrieved from PubMed, Highwire and Embase databases. Main outcome measures: The primary outcomes were pulmonary function parameters [FEV1 (forced expiratory volume in 1 second), a.m. PEF (a.m. peak expiratory flow) and p.m. PEF (p.m. peak expiratory flow)]. Secondary outcomes included differential eosinophil counts in sputum and peripheral blood, asthma control questionnaire-5 (ACQ-5) and concomitant use of medication. Pooled SMDs (standardized mean differences) were estimated by using a random-effect model and a fixed-effect model based on between-study heterogeneity. Results: Of 242 studies identified, ten (N = 4070) met the inclusion criteria (seven of budesonide-based interventions, two of fluticasone and one unknown ICS trial). Both smokers and non-smokers were similar in age and baseline FEV1. Smoking yielded considerably reduced mean change in FEV1 [SMD = −0.197, 95% CI: (−0.327, −0.066), p = 0.003], morning PEF [SMD = −0.796, 95% CI: (−1.047, −0.545), p < 0.001], night-time PEF [SMD = −0.501, 95% CI: (−0.797, −0.204), p = 0.001] and post-treatment FEV1 [SMD = −0.178, 95% CI: (−0.309, −0.046), p = 0.008] and increased use of concomitant medications [SMD = 0.537, 95% CI: (0.166, 0.908), p = 0.005] in smokers, but not non-smokers with asthma, although there was no statistical difference in allergy-related endpoints and asthma score (ACQ-5). Conclusion: Smoking is associated with attenuated response to inhaled corticosteroids in asthmatics. This offers a rationale for persuasion of smoking cessation. Treatment outcomes might be improved by smoking cessation leading to improved lung function and ameliorated symptoms.

[1]  J. Haughney,et al.  Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study. , 2012, Respiratory medicine.

[2]  B. Lipworth,et al.  Fluticasone/Salmeterol combination confers benefits in people with asthma who smoke. , 2012, Chest.

[3]  L. Boulet,et al.  Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults , 2010, The open respiratory medicine journal.

[4]  V. Backer,et al.  Asthma Patients Who Smoke Have Signs of Chronic Airflow Limitation Before Age 45 , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[5]  W. Busse,et al.  The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. , 2009, Chest.

[6]  N. Thomson,et al.  Asthma in smokers: challenges and opportunities , 2009, Current opinion in pulmonary medicine.

[7]  C. Kercsmar,et al.  Inhaled corticosteroids in asthma management. , 2008, Respiratory care.

[8]  F. Forastiere,et al.  Asthma in the elderly: mortality rate and associated risk factors for mortality. , 2007, Chest.

[9]  N. Siafakas,et al.  Cigarette smoking alters bronchial mucosal immunity in asthma. , 2007, American journal of respiratory and critical care medicine.

[10]  E. Israel,et al.  Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. , 2007, American journal of respiratory and critical care medicine.

[11]  J. Cidlowski,et al.  The Physiology of Human Glucocorticoid Receptor β (hGRβ) and Glucocorticoid Resistance , 2006 .

[12]  D. Postma,et al.  Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex , 2005, Thorax.

[13]  N. Thomson,et al.  Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma , 2005, Thorax.

[14]  N. Thomson,et al.  Glucocorticoid receptor α:β ratio in blood mononuclear cells is reduced in cigarette smokers , 2004 .

[15]  N. Thomson,et al.  Glucocorticoid receptor alpha:beta ratio in blood mononuclear cells is reduced in cigarette smokers. , 2004, The Journal of allergy and clinical immunology.

[16]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[17]  Edwin D Boudreaux,et al.  Cigarette smoking among asthmatic adults presenting to 64 emergency departments. , 2003, Chest.

[18]  D. Jacobs,et al.  Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. , 2002, American journal of respiratory and critical care medicine.

[19]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[20]  K. J. Macleod,et al.  Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma , 2002, Thorax.

[21]  P. Lange,et al.  Cigarette smoking and asthma. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[22]  I. Adcock,et al.  Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  V. Siroux,et al.  Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. , 2000, The European respiratory journal.

[24]  S. Thompson,et al.  Detecting and describing heterogeneity in meta-analysis. , 1998, Statistics in medicine.

[25]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[26]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[27]  P. Lange,et al.  Mortality in adults with self-reported asthma , 1996, The Lancet.

[28]  R. Dahl,et al.  Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. , 1996, American journal of respiratory and critical care medicine.

[29]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[30]  P. Lange,et al.  Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. , 1996, Lancet.

[31]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.